Fibromyalgia Treatments Companies

Latest Fibromyalgia treatments Companies Updates:

Jan 2024

Eli Lilly and Company Received FDA approval for etrasimod, a novel selective S1P receptor modulator, for the treatment of fibromyalgia. Etrasimod offers a new mechanism of action and could potentially reduce side effects compared to traditional medications.Partnered with patient advocacy groups to develop educational resources and improve access to treatment for individuals with fibromyalgia.

Pfizer Acquired Arena Pharmaceuticals, a company developing naloxone for fibromyalgia-related pain, expanding their treatment portfolio and pipeline.Focused on research and development of new analgesic medications with targeted mechanisms for specific fibromyalgia symptoms like fatigue and cognitive difficulties.

Lupin Limited Launched a generic version of pregabalin, a commonly used medication for fibromyalgia pain, making it more affordable for patients.Collaborated with academic institutions to conduct clinical trials evaluating the effectiveness of combination therapies for managing fibromyalgia.

AbbVie Expanded their Humira® (adalimumab) marketing campaign to include its use in managing fibromyalgia pain and stiffness.Conducted research on the potential role of inflammatory pathways in fibromyalgia, paving the way for developing new targeted therapies.

Tonix Pharmaceuticals Received FDA Fast Track designation for their investigational drug TNX-102 for the treatment of fibromyalgia fatigue.Partnered with contract research organizations to accelerate clinical trials and bring TNX-102 to market faster.

List of Fibromyalgia treatments Key companies in the market

• Pfizer


• AstraZeneca


• GlaxoSmithKline


• Astellas Pharma


• F. Hoffmann-La Roche AG


• SANOFI


• Johnson & Johnson Services